Genevant
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
887 Great Northern Way Unit 155, Vancouv...Phone Number
(778) 657-6637Website
www.genevant.comRevenue
$17 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Genevant
Genevant is a business services company. It provides drug development, biologics and drug delivery formulations. The company was formed in 2018 and is based in Vancouver, Canada.Explore more
Genevant Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genevant your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Genevant had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Genevant has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Genevant has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Genevant recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Genevant
Genevant, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Genevant is spiking on competitors!
Product Launch: Get notified when Genevant launches new products
Recommended Actions
Find VP level buyers at Genevant
Find more new buyers
Compare Similar Companies to Genevant
Compare insights from companies similar to Genevant, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Private
$147.5M
2018
RR
Renuka RamanathanVice President Head of Corporate & Business Development
Company Profile Activity
Activity Insights
Genevant is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Genevant is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Genevant.
Genevant Tech Stack
A closer look at the technologies used by Genevant
See more technologies
Genevant News & Media
Arbutus Biopharma (Nasdaq: ABUS) details $2.25B Moderna patent settlement - Stock Titan
Arbutus and Genevant secure a $2.25B global settlement with Moderna, including $950M upfront in July 2026, a $1.3B contingent payment, 20% proceeds to Arbutus, and a potential Q3 2026 capital return.Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna
BASEL, Switzerland and LONDON and NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio and a subsidiary of Roivant, and Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on infectious disease, have entered into a $2.25 billion global settlement with Moderna, Inc. to resolve aGenevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
BASEL, Switzerland and VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio and a subsidiary of Roivant Sciences Ltd. (Nasdaq: ROIV), and Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that they have entered into a $2.25 billion global settlement with ModernaGenevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio (a subsidiary of Roivant Sciences, Ltd. (Nasdaq: ROIV)), and Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on infectious disease, today filed five international lawsuits seeking to enforce patents protecting their
Read more news
Top Business Services Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Genevant
Sign Up For FreeTo access detailed company insights
Genevant is a business services company. It provides drug development, biologics and drug delivery formulations. The company was formed in 2018 and is based in Vancouver, Canada.... Read More
